In a decision released May 15, 2009, the U.S. Court of Appeals for the District of Columbia upheld a Department of Transportation (DOT) regulation that requires employees who are returning to safety-sensitive duties after having completed a drug treatment program due to failing or refusing to take a drug test, to submit to return to duty and follow up testing under “direct observation” conditions.
Continue Reading D.C. Circuit Upholds “Direct Observation” Requirements for USDOT Return to Duty and Follow Up Testing
drug testing
Court Stays DOT’s Mandatory Direct Observation for Return-to-Duty and Follow-up Testing
By Porter Wright on
The U.S. Department of Transportation’s (DOT’s) previously announced mandatory direct observation of specimen collection for return-to-duty and follow-up controlled substances test has been stayed.
Continue Reading Court Stays DOT’s Mandatory Direct Observation for Return-to-Duty and Follow-up Testing
Employers Subject to the U.S. Department of Transportation’s Substance Abuse Testing Requirements Must Now Conduct Direct Observation for Return to Duty and Follow-up Testing
By Porter Wright on
Beginning November 1, 2008, employers covered by the United States Department of Transportation’s controlled-substance testing regulations must conduct direct observation collection for “return to duty” and “follow-up” controlled substance tests.
Continue Reading Employers Subject to the U.S. Department of Transportation’s Substance Abuse Testing Requirements Must Now Conduct Direct Observation for Return to Duty and Follow-up Testing